Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2011, Article ID 231475, 5 pages
http://dx.doi.org/10.1155/2011/231475
Review Article

Molecular Markers in Cutaneous Squamous Cell Carcinoma

1Department of Plastic & Reconstructive Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
2Department of Oncology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
3Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
4Division of Gastroenterology, Department of Medicine, University of Chicago, Chicago, IL, USA
5Division of Otolaryngology, Head and Neck Surgery, Department of Surgery, Samaritan Medical Center, Watertown, NY, USA
6Department of Surgery and Cancer Immunobiology Center, UT Southwestern Medical, Dallas, TX, USA

Received 16 March 2011; Accepted 4 June 2011

Academic Editor: Richard Martin

Copyright © 2011 Anthony P. Tufaro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ramos, J. Villa, A. Ruiz, R. Armstrong, and J. Matta, “UV dose determines key characteristics of nonmelanoma skin cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 12, pp. 2006–2011, 2004. View at Google Scholar · View at Scopus
  2. T. L. Diepgen and V. Mahler, “The epidemiology of skin cancer,” British Journal of Dermatology, vol. 146, supplement s61, pp. 1–6, 2002. View at Google Scholar
  3. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” Ca-A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Weinstock, “Epidemiologic investigation of nonmelanoma skin cancer mortality: the rhode island follow-back study,” Journal of Investigative Dermatology, vol. 102, no. 6, pp. 6S–9S, 1994. View at Google Scholar · View at Scopus
  5. M. Alam and D. Ratner, “Cutaneous squamous cell carcinoma,” New England Journal of Medicine, vol. 344, no. 13, pp. 975–983, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. D. E. Rowe, R. J. Carroll, and C. L. Day Jr., “Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection,” Journal of the American Academy of Dermatology, vol. 26, no. 6, pp. 976–990, 1992. View at Google Scholar · View at Scopus
  7. D. S. Preston and R. S. Stern, “Nonmelanoma cancers of the skin,” New England Journal of Medicine, vol. 327, no. 23, pp. 1649–1662, 1992. View at Google Scholar · View at Scopus
  8. C. Ulrich, T. Schmook, M. M. Sachse, W. Sterry, and E. Stockfleth, “Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients,” Dermatologic Surgery, vol. 30, no. 4, pp. 622–627, 2004. View at Google Scholar · View at Scopus
  9. S. E. Edge, D. R. Byrd, C. C. Compton et al., “Cutaneous squamous cell carcinoma and other cutaneous carcinomas,” in AJCC Cancer Staging Manual, chapter 29, pp. 301–314, Springer, New York, NY, USA, 7th edition, 2010. View at Google Scholar
  10. P. Jensen, S. Hansen, B. Moller et al., “Skin cancer in kidney and heart transplant recipients and different longterm immunosuppressive therapy regimens,” Journal of the American Academy of Dermatology, vol. 40, no. 1, pp. 177–186, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Penn, “Malignancy,” Surgical Clinics of North America, vol. 74, no. 5, pp. 1247–1257, 1994. View at Google Scholar
  12. F. J. Moloney, H. Comber, P. O'Lorcain, P. O'Kelly, P. J. Conlon, and G. M. Murphy, “A population-based study of skin cancer incidence and prevalence in renal transplant recipients,” British Journal of Dermatology, vol. 154, no. 3, pp. 498–504, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. A. Harwood, T. Surentheran, J. M. McGregor et al., “Human papilloma-virus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals,” Journal of Medical Virology, vol. 61, no. 3, pp. 289–297, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. de Villiers, D. Laverone, K. McLaren, and E. C. Benton, “Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients,” International Journal of Cancer, vol. 73, no. 3, pp. 356–361, 1997. View at Google Scholar · View at Scopus
  15. B. S. Cherpelis, C. Marcusen, and P. G. Lang, “Prognostic factors for metastasis in squamous cell carcinoma of the skin,” Dermatologic Surgery, vol. 28, no. 3, pp. 268–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. K. Barksdale, N. O'Connor, and R. Barnhill, “Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers,” Surgical Oncology Clinics of North America, vol. 6, no. 3, pp. 625–638, 1997. View at Google Scholar · View at Scopus
  17. M. Dubina and G. Goldenberg, “Viral-associated nonmelanoma skin cancers: a review,” American Journal of Dermatopathology, vol. 31, no. 6, pp. 561–573, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. A. Jackson, “Prevention, early detection and team management of skin cancer in primary care: contribution to the health of the nation objectives,” British Journal of General Practice, vol. 45, no. 391, pp. 97–101, 1995. View at Google Scholar
  19. D. Czarnecki, M. Staples, A. Mar, G. Giles, and C. Meehan, “Metastases from squamous cell carcinoma of the skin in southern Australia,” Dermatology, vol. 189, no. 1, pp. 52–54, 1994. View at Google Scholar
  20. D. Buethe, C. Warner, J. Miedler, and C. J. Cockerell, “Focus issue on squamous cell carcinoma: practical concerns regarding the 7th edition ajcc staging guidelines,” Journal of Skin Cancer, vol. 2011, Article ID 156391, 9 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  21. P. J. F. Quaedvlieg, D. H. K. V. Creytens, G. G. Epping et al., “Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips,” Histopathology, vol. 49, no. 3, pp. 256–264, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. Novick, D. A. Gard, S. B. Hardy, and M. Spira, “Burn scar carcinoma: a review and analysis of 46 cases,” Journal of Trauma, vol. 17, no. 10, pp. 809–817, 1977. View at Google Scholar · View at Scopus
  23. J. L. Andruchow, M. J. Veness, G. J. Morgan et al., “Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes,” Cancer, vol. 106, no. 5, pp. 1078–1083, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. D. S. Cassarino, D. P. DeRienzo, and R. J. Barr, “Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification,” Journal of Cutaneous Pathology, vol. 33, no. 4, pp. 261–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Asgari, N. B. Kiviat, C. W. Critchlow et al., “Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals,” Journal of Investigative Dermatology, vol. 128, no. 6, pp. 1409–1417, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. O. Forslund, H. Ly, C. Reid, and G. Higgins, “A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis,” British Journal of Dermatology, vol. 149, no. 1, pp. 64–73, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Zur Hausen, “Papillomaviruses and cancer: from basic studies to clinical application,” Nature Reviews Cancer, vol. 2, no. 5, pp. 342–350, 2002. View at Google Scholar · View at Scopus
  28. S. Syrjänen, “The role of human papillomavirus infection in head and neck cancers,” Annals of Oncology, vol. 21, supplement 7, pp. vii243–vii245, 2010. View at Publisher · View at Google Scholar · View at PubMed
  29. A. S. Patel, M. R. Karagas, A. E. Perry, and H. H. Nelson, “Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus β-types in a population-based study,” Journal of Investigative Dermatology, vol. 128, no. 12, pp. 2888–2893, 2008. View at Publisher · View at Google Scholar · View at PubMed
  30. H. Feng, M. Shuda, Y. Chang, and P. S. Moore, “Clonal integration of a polyomavirus in human Merkel cell carcinoma,” Science, vol. 319, no. 5866, pp. 1096–1100, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. L. Reed, J. Califano, P. Cairns et al., “High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma,” Cancer Research, vol. 56, no. 16, pp. 3630–3633, 1996. View at Google Scholar · View at Scopus
  32. R. van Doorn, N. A. Gruis, R. Willemze, P. A. van der Velden, and C. P. Tensen, “Aberrant DNA methylation in cutaneous malignancies,” Seminars in Oncology, vol. 32, no. 5, pp. 479–487, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. P. van der Riet, H. Nawroz, R. H. Hruban et al., “Frequent loss of chromosome 9p21-22 early in head and neck cancer progression,” Cancer Research, vol. 54, no. 5, pp. 1156–1158, 1994. View at Google Scholar · View at Scopus
  34. S. E. Gray, E. Kay, M. Leader, and M. Mabruk, “Analysis of p16 expression and allelic imbalance/loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas,” Journal of Cellular and Molecular Medicine, vol. 10, no. 3, pp. 778–788, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. K. J. Purdie, S. R. Lambert, M. T. Teh et al., “Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis,” Genes Chromosomes and Cancer, vol. 46, no. 7, pp. 661–669, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. R. J. Gibbons, “Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes,” Human Molecular Genetics, vol. 14, no. 1, pp. R85–R92, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. K. N. Bhalla, “Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies,” Journal of Clinical Oncology, vol. 23, no. 17, pp. 3971–3993, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. Esteller, “The necessity of a human epigenome project,” Carcinogenesis, vol. 27, no. 6, pp. 1121–1125, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. I. Venza, M. Visalli, B. Tripodo et al., “FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma,” British Journal of Dermatology, vol. 162, no. 5, pp. 1093–1097, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. E. Laing, R. Cummins, A. O'Grady, P. O'Kelly, E. W. Kay, and G. M. Murphy, “Aberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients,” British Journal of Dermatology, vol. 163, no. 2, pp. 345–352, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. J. F. Costello, M. C. Frühwald, D. J. Smiraglia et al., “Aberrant CpG-island methylation has non-random and tumour-type-specific patterns,” Nature Genetics, vol. 24, no. 2, pp. 101–102, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. M. Esteller, P. G. Corn, S. B. Baylin, and J. G. Herman, “A gene hypermethylation profile of human cancer,” Cancer Research, vol. 61, no. 8, pp. 3225–3229, 2001. View at Google Scholar
  43. A. Kapoor, M. S. Goldberg, L. K. Cumberland et al., “The histone variant macroH2A suppresses melanoma progression through regulation of CDK8,” Nature, vol. 468, no. 7327, pp. 1105–1109, 2010. View at Publisher · View at Google Scholar · View at PubMed
  44. C. Tzao, H.-J. Tung, J.-S. Jin et al., “Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus,” Modern Pathology, vol. 22, no. 2, pp. 252–260, 2009. View at Publisher · View at Google Scholar · View at PubMed
  45. J. Yu, D. G. Ryan, S. Getsios, M. Oliveira-Fernandes, A. Fatima, and R. M. Lavker, “MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19300–19305, 2008. View at Publisher · View at Google Scholar · View at PubMed
  46. C. Dang, M. Gottschling, K. Manning et al., “Identification of dysregulated genes in cutaneous squamous cell carcinoma,” Oncology Reports, vol. 16, no. 3, pp. 513–519, 2006. View at Google Scholar
  47. P. Dziunycz, G. Iotzova-Weiss, J. J. Eloranta et al., “Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation,” Journal of Investigative Dermatology, vol. 130, no. 11, pp. 2686–2689, 2010. View at Publisher · View at Google Scholar · View at PubMed
  48. S. E. Durham, K. J. Krishnan, J. Betts, and M. A. Birch-Machin, “Mitochondrial DNA damage in non-melanoma skin cancer,” British Journal of Cancer, vol. 88, no. 1, pp. 90–95, 2003. View at Publisher · View at Google Scholar · View at PubMed
  49. S. L. Prior, A. P. Griffiths, and P. D. Lewis, “A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer,” British Journal of Dermatology, vol. 161, no. 5, pp. 1067–1071, 2009. View at Publisher · View at Google Scholar · View at PubMed
  50. A. Harbottle and M. A. Birch-Machin, “Real-time PCR analysis of a 3895 bp mitochondrial DNA deletion in nonmelanoma skin cancer and its use as a quantitative marker for sunlight exposure in human skin,” British Journal of Cancer, vol. 94, no. 12, pp. 1887–1893, 2006. View at Publisher · View at Google Scholar · View at PubMed